AGI AGI

 

TIDMAGI 
 
RNS Number : 3883I 
AGI Therapeutics plc 
10 March 2010 
 

 
 
                              AGI Therapeutics PLC 
 
                            Notification of Results 
 
AGI Therapeutics plc ("AGI" or the "Company") (AIM, IEX: AGI), a speciality 
pharmaceutical company, will be announcing its preliminary results for the year 
ended 31 December 2009 on Wednesday, 14th April 2009. 
 
 
 
Contact Information: 
 
+------------------------------+-------------------------+ 
| AGI Therapeutics plc.        | Tel: +353 1 449 3254    | 
+------------------------------+-------------------------+ 
| David Kelly, Chief Financial |                         | 
| Officer                      |                         | 
+------------------------------+-------------------------+ 
|                              |                         | 
+------------------------------+-------------------------+ 
|                              |                         | 
+------------------------------+-------------------------+ 
| Davy                         | Tel: +353 (1) 614 6363  | 
| John Frain                   |                         | 
+------------------------------+-------------------------+ 
|                              |                         | 
+------------------------------+-------------------------+ 
 
 
Notes to Editors: 
 
About AGI Therapeutics plc 
 
AGI is a specialty pharmaceutical company which is focused on the development 
and commercialisation of differentiated specialty drug products to treat unmet 
medical needs, including conditions which qualify for Orphan drug status. 
 
The Company aims to bring its products to the market either directly or through 
out-licensing or other partnering arrangements. 
 
AGI's common shares are listed on the Alternative Investment Market of the 
London Stock Exchange (AIM) and on the Irish Enterprise Exchange of the Irish 
Stock Market (IEX) as AGI. 
 
For further information please see www.agitherapeutics.com 
 
 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 NORMMGMFKGGGGZM 
 

AGI (LSE:AGI)
Gráfica de Acción Histórica
De Abr 2024 a May 2024

AGI (LSE:AGI)
Gráfica de Acción Histórica
De May 2023 a May 2024